Crohn’s Disease (CD) is a type of Inflammatory Bowel Disease (IBD) that causes inflammation in the digestive tract. It can lead to a range of symptoms, including abdominal pain, diarrhea, weight loss, malnutrition, fatigue, and inflammation. Crohn’s Disease can affect different areas of the digestive tract in different individuals. In more severe or advanced cases, inflammation can spread to the deeper layers of the bowel and surrounding organs.

CD can be both debilitating and painful, with the potential to cause serious, life-threatening complications. While there is no cure for Crohn’s Disease, various therapies and medications are available to help manage symptoms and reduce inflammation. Although it is a chronic condition, treatment can often lead to periods of remission where symptoms improve or disappear.

The exact cause of Crohn’s Disease (CD) is not fully understood, but several factors are believed to contribute to its development:

1.    Immune System Response: Certain bacteria and viruses may trigger an abnormal immune response in the digestive tract, leading to inflammation and the onset of Crohn’s Disease.

2.    Genetics: Individuals with a family history of Crohn’s Disease are at a higher risk. Genetic predisposition plays a significant role in increasing susceptibility to the condition.

3.    Age and Gender: Crohn’s Disease is more commonly diagnosed in younger individuals, particularly before the age of 30. Additionally, studies have shown that individuals of African descent in the United Kingdom and North America have a higher risk of developing the disease.

The most common symptoms of Crohn's disease include:

·       Cramping and abdominal pain

·       Fatigue, fever, and diarrhea

·       Bloody stools and mouth sores

·       Weight loss and loss of appetite

·       Pain or drainage around the anus due to inflammation in fistulas (abnormal connections between tissues)

Crohn’s disease can affect different parts of the large and small intestines, with many patients experiencing involvement of the large intestine and colon. Symptoms can vary in severity, ranging from mild to severe. While these symptoms usually develop gradually, in some cases they can appear suddenly.

The treatment of Crohn's Disease (CD) typically involves a combination of medications, nutritional support, and sometimes surgery. The primary goal of treatment is to reduce inflammation, manage symptoms, and prevent complications. Treatment options include:

Medications:

·       Anti-inflammatory drugs: To reduce inflammation in the digestive tract.

·       Corticosteroids: For short-term control of flare-ups.

·       Oral 5-aminosalicylates: Often used to manage mild to moderate inflammation.

·       Immune system suppressants: To reduce the immune system's attack on the gastrointestinal tract, including:

o   Azathioprine

o   Mercaptopurine

o   Methotrexate

·       Biologic therapies: To target specific components of the immune response, including:

o   Vedolizumab

o   Natalizumab

o   Infliximab

o   Ustekinumab

o   Adalimumab

o   Certolizumab

·       Other medications: To address complications and symptoms, such as:

o   Antibiotics

o   Vitamins and supplements

o   Pain relievers

o   Antidiarrheal drugs

Recent studies indicate that Stem Cell Therapy (SCT) using bone marrow-derived Mesenchymal Stem Cells (MSCs) can significantly reduce the activity of Crohn’s Disease (CD), thereby improving the quality of life and prognosis for chronic patients. Crohn’s Disease frequently leads to the development of fistulas—abnormal connections between body parts that cause pain and irritation.

Clinical data shows that approximately 75% of patients with fistulas experienced complete closure following MSC therapy. Furthermore, this therapy has demonstrated long-lasting effects, with benefits persisting for over four years after a single treatment session.

Research suggests that Stem Cell Therapy represents a promising and innovative treatment for inflammatory bowel diseases (IBD), including Crohn’s Disease. MSCs have proven to be a reliable source for tissue regeneration and repair in patients suffering from chronic digestive tract damage and inflammation. In addition to addressing the disease-related symptoms, Stem Cell Therapy has been shown to reduce the frequency of flare-ups and recurrences. MSCs also exhibit potent immunomodulatory effects, helping to regulate abnormal immune responses, making the therapy not only effective but also safe, with minimal side effects.

In addition to MSCs, Hematopoietic Stem Cells (HSCs) have also shown promise in alleviating symptoms of Crohn’s Disease and restoring immune tolerance in patients.

In Crohn’s Disease, Stem Cell Therapy can help by:

·       Reducing intestinal inflammation

·       Promoting long-term healing of the intestinal mucosa

·       Significantly improving patient quality of life

·       Addressing Crohn’s disease-related perianal fistulas and other complications related to IBD

Clinical literature suggests that exosome therapy combined with mesenchymal stem cells (MSCs) plays a significant role in treating autoimmune diseases by regulating inflammatory cytokines, the cellular microenvironment, and immune responses. This approach has a strong influence on both adaptive and innate immune cells, with key players including macrophages, T regulatory cells (Tregs), Th17 cells, immunoregulatory miRNAs, and CD4+ Th1 cells.

In autoimmune conditions, exosome-MSC therapy helps modulate T-cell subsets. Specifically, it reduces the levels of pro-inflammatory cytokines associated with Th17 and Th1 cells, such as IL-17AF, IL-12p70, and IL-6, while increasing the concentration of anti-inflammatory Tregs. By enhancing Treg cell production, exosome-MSC therapy aids in maintaining immunoregulation without altering the overall lymphocyte count.

This therapeutic effect has been observed in autoimmune conditions such as rheumatoid arthritis (RA) and graft-versus-host disease (GVHD). In GVHD, exosome-MSCs improve patient outcomes by suppressing the differentiation of naïve T-cell populations.

Macrophages, which are critical components of innate immunity, are also influenced by exosome-MSC therapy. Depending on the microenvironment, naïve macrophages (Mo) can be polarized into pro-inflammatory (M1) or anti-inflammatory (M2) phenotypes, allowing them to perform distinct roles in various disease states. Exosome-MSC therapy can promote the conversion of M1 macrophages to M2, thereby reducing pro-inflammatory responses.

In addition to treating autoimmune diseases, this combination therapy shows promise in regulatingmetabolic homeostasis, potentially attenuating obesity and reducing adipose inflammation by promoting the anti-inflammatory actions of M2 macrophages.

At Renue we believe that if you are truly interested in Healthspan (Living better, not just longer.”) then it’s important that we are aware of our Biological Age vs Chronological Age.  Remember you can”t measure success without a starting point.  With TruDiagnostic’s TruAge testy you will receive 9 personalized Epigenetic Health Scores and actionable insights to slow aging

Biological Age

How old your body is compared to your real age

Pace of Aging

How quickly you're aging each year

Organ System Ages

The age of key organs (heart, brain, liver, etc.)

Fitness Age

Your physical health based on strength, lung capacity, and movement

Smoking Impact

How smoking has affected your epigenetic age

Alcohol Impact

How alcohol consumption has influenced your health

Stem Cell Therapy is the most dependable procedure for Crohn’s Disease now. Generally, Stem Cell Therapy has a satisfactory safety profile, good prognosis, and effectiveness. 

However, no medical procedure is 100% safe; so, the most frequent or common risk factors of SCT can be:

• Allergic reactions

• Bleeding from the site of injection

• Fever

• Painful injection area /site

• Lethargy and fatigue

Pre-treatment education can help with awareness of slight side effects of the therapy. Allergic reactions are preventable through pre-injection history and care. Bleeding and swelling of the injured site are manageable via proper technique. Fever, lethargy, and pain are managed through the appropriate drugs along with the treatment.